Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vaglini

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Tumori|February 1, 1980
HLA antigens in malignant melanoma patientsG Pellegris, M T Illeni, M Vaglini, et al.
International Journal of Cell Cloning|November 1, 1989
Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanomaN Zaffaroni, R Villa, M G Daidone, et al.
Thrombosis Research|February 1, 1996
Hypercoagulability and hyperfibrinolysis in patients with melanomaB Bottasso, D Mari, R Coppola, et al.
International Journal of Cancer|June 15, 1982
HLA complex and familial malignant melanomaG Pellegris, M T Illeni, D Rovini, et al.
International Journal of Oncology|May 18, 2011
Reliability of a primary culture system to test cytotoxic drug activity in human-malignant melanomaR Villa, N Zaffaroni, L Orlandi, et al.
Anti-Cancer Drugs|July 1, 1996
Modulation of melphalan cytotoxic activity in human melanoma cell linesR Supino, C Caserini, L Orlandi, et al.
Tumori|December 31, 1983
Regional perfusion at high temperature in treatment of stage IIIA-IIIAB melanoma patientsM Vaglini, M Ammatuna, M Nava, et al.
Cell Proliferation|November 1, 1995
Effect of melphalan and hyperthermia on cell cycle progression and cyclin B1 expression in human melanoma cellsL Orlandi, N Zaffaroni, A Bearzatto, et al.
British Journal of Cancer|November 1, 1990
Cell kinetics: an independent prognostic variable in stage II melanoma of the skinA Costa, R Silvestrini, G Mezzanotte, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1989
Early presence of activated ('exhausted') platelets in malignant tumors (breast adenocarcinoma and malignant melanoma)P M Mannucci, M Cattaneo, M T Canciani, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Tumori|February 1, 1980
HLA antigens in malignant melanoma patientsG Pellegris, M T Illeni, M Vaglini, et al.
International Journal of Cell Cloning|November 1, 1989
Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanomaN Zaffaroni, R Villa, M G Daidone, et al.
Thrombosis Research|February 1, 1996
Hypercoagulability and hyperfibrinolysis in patients with melanomaB Bottasso, D Mari, R Coppola, et al.
International Journal of Cancer|June 15, 1982
HLA complex and familial malignant melanomaG Pellegris, M T Illeni, D Rovini, et al.
International Journal of Oncology|May 18, 2011
Reliability of a primary culture system to test cytotoxic drug activity in human-malignant melanomaR Villa, N Zaffaroni, L Orlandi, et al.
Anti-Cancer Drugs|July 1, 1996
Modulation of melphalan cytotoxic activity in human melanoma cell linesR Supino, C Caserini, L Orlandi, et al.
Tumori|December 31, 1983
Regional perfusion at high temperature in treatment of stage IIIA-IIIAB melanoma patientsM Vaglini, M Ammatuna, M Nava, et al.
Cell Proliferation|November 1, 1995
Effect of melphalan and hyperthermia on cell cycle progression and cyclin B1 expression in human melanoma cellsL Orlandi, N Zaffaroni, A Bearzatto, et al.
British Journal of Cancer|November 1, 1990
Cell kinetics: an independent prognostic variable in stage II melanoma of the skinA Costa, R Silvestrini, G Mezzanotte, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1989
Early presence of activated ('exhausted') platelets in malignant tumors (breast adenocarcinoma and malignant melanoma)P M Mannucci, M Cattaneo, M T Canciani, et al.
Pageof 7